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Background: Almost nothing is known about the medical aspects of runners doing a transcontinental
ultramarathon over several weeks. The results of differentiated measurements of changes in body composition
during the Transeurope Footrace 2009 using a mobile whole body magnetic resonance (MR) imager are presented
and the proposed influence of visceral and somatic adipose and lean tissue distribution on performance tested.
Methods: 22 participants were randomly selected for the repeated MR measurements (intervals: 800 km) with a 1.5
Tesla MR scanner mounted on a mobile unit during the 64-stage 4,486 km ultramarathon. A standardized and
validated MRI protocol was used: T1 weighted turbo spin echo sequence, echo time 12 ms, repetition time 490 ms,
slice thickness 10 mm, slice distance 10 mm (breath holding examinations). For topographic tissue segmentation
and mapping a modified fuzzy c-means algorithm was used. A semi-automatic post-processing of whole body MRI
data sets allows reliable analysis of the following body tissue compartments: Total body volume (TV), total somatic
(TSV) and total visceral volume (TVV), total adipose (TAT) and total lean tissue (TLT), somatic (SLT) and visceral lean
tissue (VLT), somatic (SAT) and visceral adipose tissue (VAT) and somatic adipose soft tissue (SAST). Specific volume
changes were tested on significance. Tests on difference and relationship regarding prerace and race performance
and non-finishing were done using statistical software SPSS.
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Results: Total, somatic and visceral volumes showed a significant decrease throughout the race. Adipose tissue
showed a significant decrease compared to the start at all measurement times for TAT, SAST and VAT. Lean adipose
tissues decreased until the end of the race, but not significantly. The mean relative volume changes of the different
tissue compartments at the last measurement compared to the start were: TV −9.5% (SE 1.5%), TSV −9.4% (SE 1.5%),
TVV −10.0% (SE 1.4%), TAT −41.3% (SE 2.3%), SAST −48.7% (SE 2.8%), VAT −64.5% (SE 4.6%), intraabdominal adipose
tissue (IAAT) −67.3% (SE 4.3%), mediastinal adopose tissue (MAT) −41.5% (SE 7.1%), TLT −1.2% (SE 1.0%), SLT −1.4%
(SE 1.1%). Before the start and during the early phase of the Transeurope Footrace 2009, the non-finisher group had
a significantly higher percentage volume of TVV, TAT, SAST and VAT compared to the finisher group. VAT correlates
significantly with prerace training volume and intensity one year before the race and with 50 km- and 24 hour-race
records. Neither prerace body composition nor specific tissue compartment volume changes showed a significant
relationship to performance in the last two thirds of the Transeurope Footrace 2009.
Conclusions: With this mobile MRI field study the complex changes in body composition during a multistage
ultramarathon could be demonstrated in detail in a new and differentiated way. Participants lost more than half of
their adipose tissue. Even lean tissue volume (mainly skeletal muscle tissue) decreased due to the unpreventable
chronic negative energy balance during the race. VAT has the fastest and highest decrease compared to SAST and
lean tissue compartments during the race. It seems to be the most sensitive morphometric parameter regarding
the risk of non-finishing a transcontinental footrace and shows a direct relationship to prerace-performance.
However, body volume or body mass and, therefore, fat volume has no correlation with total race performances of
ultra-athletes finishing a 4,500 km multistage race.
Keywords: Magnetic resonance imaging, MRI, Body mass, Body volume, Body composition, Running, Marathon,
Ultramarathon, Performance, Adipose tissue, Body fat, Lean tissue, Visceral, Somatic, Topography, Segmentation,
MappingBackground
With the worldwide growing number of people running,
endurance sports have experienced differentiation into
multiple (sub-) disciplines in the last decades. Concerning
distance running, the ultramarathon (UM) seems to be
the greatest challenge in endurance running. The German
Ultramarathon Association (DUV) defines footraces of 50
km or longer as UM. However, as in every field of human
physical activities, some people try to push themselves to
the limits and beyond. For these ultra-athletes a multistage
ultramarathon (MSUM) is the ultimate test of endurance
performance. Sometimes, the worldwide small group of
ultra-endurance runners meet with each other trying to
achieve the impossible: finishing a multistage transcontin-
ental footrace over thousands of kilometers. These most
extreme multistage endurance competitions in the world
take the runner to a different level, where nutrition, sleep,
energy and psychological states have to be carefully man-
aged. Besides a few case reports, almost nothing has been
reported about the medical aspects of runners doing a
transcontinental extended MSUM over several weeks [1].
Until now, there have been no series published regarding
UM running over more than 1,500 km. However, prolonged
ultra-endurance footraces offer the best opportunity to
study physical adaptations and the relationships of the
physiological parameters in endurance athletes.
The Transeurope Footrace Project (TEFR-project) [2]
is the first observational cohort field study of atranscontinental MSUM, the Transeurope Footrace 2009
(TEFR09) [3]. A unique group of 67 endurance runners
(mean age 50.7 years, standard deviation (SD) 10.5 years,
range 26 to 74 years, m 56 (83.6%)) met the challenge
and tried to cross six countries while running 4,486 km
in 64 stages (mean 70.1 km, min 44 km, max 95.1 km)
without any day of rest [4]. The central aspect of the
TEFR-project was the use of a mobile magnetic reson-
ance imaging (MRI) scanner accompanying the TEFR09
participants on a truck trailer over 64 days under their
‘natural’ conditions [2].
One focus of this presentation is on the descriptive pres-
entation of characteristics and changes in body compos-
ition during TEFR09 in a new way, differentiating between
somatic and visceral and segmental volumes of defined fat
and lean tissue compartments measured by continuous
mobile whole body MRI. In addition, possible associations
of body volume composition and prerace and race per-
formance were analyzed to test the following hypotheses:
it is hypothesized, that prerace endurance running per-
formance is related to specific body fat and lean tissue
composition in ultra-athletes. Secondarily, it is supposed,
that although the running distance of a transcontinental
UM cannot be trained for concerning the running volume
(km), participants need specific prerace performance skills
and fat and lean tissue volume distribution, if they want to
finish such a race. Due to the expected huge energy bur-
den a transcontinental footrace without any day of rest
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every participant to lose body mass and total body volume
(TV) due to massive adipose tissue decrease and more or
less lean tissue catabolism. At least, with the continuous
differentiated measurement of body tissue compartments
throughout the entire TEFR09, it should be shown indir-
ectly, that although the participants are preselected in
regard to their ultra endurance running expertise, they will




Every TEFR09 participant was asked to join the TEFR-
project, which was approved by the local ethics commit-
tee of the University Hospital of Ulm (UHU, No.: 270/
08-UBB/se) in accordance with the Declaration of
Helsinki, regarding the study design, risk management
plan and individual protocols [2]. Forty-four participants
(67%) were recruited for the study and gave their in-
formed written consent. Every second subject (n = 22,
20 men, mean age 49.1 years, SD 11.5 yrs., range 27 to
69 years) was randomly selected for whole body MRI
measurements regarding body composition. According
to project protocol these subjects underwent a whole
body MRI before the start at Bari (South Italy) and dur-
ing the race in measurement intervals of approximately
800 km. Due to various reasons, deviations from
planned measurement intervals (MI: t0 to t6) occurred.
The mean deviation of actual from planned measure-
ment intervals was 187.8 km (SD = 141.3 km) [2].
Prerace performance
Before the start of TEFR09 all subjects filled out specific
questionnaires concerning their prerace experience in en-
durance running. This history includes the years of regular
endurance running (PRY), the number of finished (nF)
marathons (M), UM and MSUM, and the prerace records
(PRR) for marathon and specific UM (50 km, 100 km, 6
hours, 12 hours, 24 hours) races within the last decade be-
fore TEFR. It also includes the extent of prerace training
(PRT) 16 months before TEFR09: training volume (Vol:
km/week), training duration (Time: hours/week) and
the training intensity (Int: km/hour). The self-
disclosures about nF and PRR were cross checked with
the archive of the DUV and discrepancies were clari-
fied. However, for PRT and PRY we had to rely solely
on the self-disclosures; these could not be compared
with any official lists.
Body composition analysis
Different techniques for quantification of body fat are
described and more or less commonly used in the litera-
ture:. In vivo, two-compartment model methods are thehydrodensitometry [5] and the body fat percentage and
muscle mass calculation from anthropometric data such
as skinfold thickness (SF) calipometry and/or segmental
body circumferences (CF) [6-8]. Three-compartment
methods are the bioelectrical impedance analysis (BIA)
[9] and dual-energy X-ray absorptiometry (DEXA) [10].
Using these methods, indirect measurement, approxi-
mated calculation or simple estimation of total, regional
or local adipose or lean tissue [11-14] is possible. In con-
trast, a whole body MRI assessment of adipose tissue as
a multi-compartment method is the only method enab-
ling exact topographic tissue mapping and tissue seg-
mentation. Therefore, it is the gold standard imaging
tool for differentiated assessment of adipose or lean
tissue distribution in the body [15-18].
Subjects who finished TEFR09 had whole body MRI
six times during TEFR09 (seven measurements in total).
Measurement of body mass (BM) was done at the same
time as MRI and every fourth day: BIA balance Tanita
BC-545 to the nearest 0.1 kg (Tanita, Arlington Heights,
IL, U.S.A.). Body height was measured with a wall-
mounted stadiometer (to the nearest 5 mm, standing bare-
foot) and body mass index (BMI) was calculated.
Mobile whole body MRI
For whole body magnetic resonance (MR) measure-
ments a 1.5 Tesla MRI scanner (Magnetom Avantot™,
Siemens Ltd., Erlangen, Germany) mounted on a mobile
unit (MRI-Trailer, SMIT Mobile Equipment B.V., Great
Britain) was used. The total 45 tonnes of equipment
(MRI-trailer, truck tractor, external 105KVA diesel-
generator, and material van) was built up and taken
down daily at each stopover of TEFR09, requiring daily
checks and support of all technical systems [2].
Several MRI techniques have been described for the
measurement and quantification of body fat compos-
ition: T1-weighted imaging by spin-echo or gradient-
echo techniques [14,16,19], chemical shift selective
(CHESS) imaging [20-22], or DIXON techniques [23,24].
All of them have specific advantages and disadvantages,
the details of which are beyond the scope of this article.
For analysis of body composition a standardized assess-
ment of whole body adipose tissue measurement based
on a MRI protocol according to Machann et al. [25] was
used. A two-dimensional T1-weighted turbo spin echo
sequence with an echo train length of seven was applied
(Siemens Ltd.). Measurement parameters were set to be:
flip angle 180°, echo time 12 ms, repetition time 490 ms,
slice thickness 10 mm, slice distance 10 mm, 5 slices per
sequence, field of view 1,991 cm2, matrix size 256 × 196
was recorded in a measuring time of 12 seconds
(allowing breath holding examinations in the trunk
area), bandwidth 120 Hz/pixel. A total of 90 to 120 im-
ages were generated, depending on the size of the
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25 minutes including one rearrangement of prone po-
sitioned subject (head forward and arms extended for
upper body, feet forward for lower body), as total table
feed of the MR-imager is limited to 110 cm. In order
to guarantee identical slice positions after reposi-
tioning, the subjects were marked at the iliac crest. A
body coil was used.
Image post-processing
For topographic tissue segmentation and mapping of the
athletes body a fuzzy c-means algorithm according to
Würslin et al. [26] was used. This approach provides a
simple and time-saving strategy for assessment and
standardization of individual adipose tissue distribution
in the entire body. Due to standardization using defined
internal markers, it enables a completely automatic, reli-
able analysis and creation of adipose tissue distribution
profiles of the whole body from the multislice MR
datasets and makes a reliable comparison of subjects
with different body structure possible [25,26].
The signal of intestinal content with a short T1can be
interpreted as visceral adipose tissue (VAT) in the absence
of intraluminal gastroenteric nutrition fat (INF). If the
scanned subject is in a non-fasting condition, the visceral
T1 signal occurs from both, VAT and INF. Reliability
(mean absolute deviation of three repeated measure-
ments) is noted with 3.08% for total volume (TV), 1.48%
for total adipose tissue (TAT) and 1.13% for visceral adi-
pose tissue (VAT) [26].
Due to their immense mental and physical stress
caused by the daily ultra-endurance burden, the runners’
biggest fear was losing too much energy over the course
of TEFR09. Their primary effort after stage finishing was
to get as much nutrition and calories as possible before
falling asleep. Therefore, it was not always possible to
ensure fasting conditions of the subjects for mobile MRI
measurements. Some subjects were motivated enough to
do the MR examination directly after the daily stage be-
fore eating in a fasting but exhausted condition, so they
sometimes were not able to lie absolutely still on the
MR table and follow the breath commands exactly.
These specific circumstances resulted in the image post-
processing analysis being less automated than that men-
tioned by Machann and Würslin [25,26]: Movement
artifacts had to be cleared manually more often before
automatic post-processing. Compared to normal or
overweight patients, in thin and lean bodies the amount
of adipose bone marrow (ABM) and INF is more rele-
vant in relation to whole body adipose and lean tissue.
At the start of TEFR09, ABM and INF together
accounted for 13.2% of total adipose tissue. Due to the
continuous loss of adipose body tissue, this ratio rises up
to 28.2% until the end of the race. For visceral adiposetissue, INF rose from 3% at the start up to 65.4% at the
end of TEFR09. Therefore, a manual separation of ABM
(Figure 1) and INF (Figure 2) was done on all MR slices
of the subjects. Looking at the mean differences,
Würslin et al. [26] calculated between manual tissue
segmentation and their automatic procedure (2.07% for
TV, 8.13% for TAT, 3.21% for VAT), the described add-
itional manual corrections regarding the small volumes
of ABM and INF are appropriate.
After these procedures a specific and extensive topo-
graphic mapping and segmentation of body tissue was
possible (Table 1). Total volume (TV) can be subdivided
into total somatic volume (TSV) and total visceral
volume (TVV, Figure 2) or can be subdivided into total
adipose tissue (TAT; without INF) and total lean tissue
(TLT). TLT can be separated into somatic (SLT) and vis-
ceral lean tissue (VLT). Subtraction of ABM from TAT
leads to total adipose soft tissue (TAST). TAST can be
subdivided into VAT and somatic adipose soft tissue
(SAST). Therefore, somatic adipose tissue (SAT, Figure 1)
is the same as SAST plus ABM or TAT minus VAT,
respectively. VAT can be subdivided into intraabdominal
(retro- and intraperitoneal) adipose tissue (IAAT) and
intrathoracic, mainly mediastinal adipose tissue (MAT).
Body segmentation was done into upper extremities (UE),
trunk (TR) and lower extremities (LE). TV, lean tissue
(LT) and SAST volume was calculated for the upper and
lower extremities (UE and LE) and for the trunk (TR). For
nomenclature of specific segmented tissues see Table 1.
Statistical analysis
For data elaboration specific software was used: Microsoft™
Office Excel™ (Release 12.0.6665.5003, Microsoft Home
and Student Suite, 2007, Microsoft Inc.) for data documen-
tation, SPSS (IBM™ SPSS™ Statistics, Release 19.0.0, 2010,
SPSS Inc.) for statistical analysis and SigmaPlot for
Windows Version 11.0 (Release 11.2.0.5, 2008, Systat Soft-
ware Inc.,) for graphical data presentation.
The measured volumes of tissue compartments are
presented as percentage volumes (vol%) and as absolute [1]
and relative differences (%) to start. For every measure-
ment interval (t0 to t5) the dispersion measures are
presented graphically in box plot figures (median, 25th/
75th percentile, 10th/90th percentile and all outliers) for all
subjects (finishers and non-finishers) and location mea-
sures (mean and standard error, SE) are presented graphic-
ally in line figures for finishers only. Calculated total
changes (t5 versus t0) of volumes and volume percentages
are presented in text as means and standard deviation (SD)
with minimum (min) and maximum (max) as appropriate.
Analyses on volume changes during TEFR09
For analysis of the significance regarding volume changes
of the specific tissue compartments during TEFR09, a
Figure 1 Semiautomatic separation of adipose bone marrow:
selected slices from whole body MRI of a 32-year-old male
finisher of TEFR09. I: ankles, II: middle of lower legs, III: knees,
IV: middle of upper legs, V: hip/pelvis, VI: umbilical level, VII: upper
abdomen, VIII: heart/mediastinum, IX: shoulder girth, X: elbows. Left
row: before start (t0), green: TLT, red: SAST, yellow: VAT+INF, blue:
ABM. Right row: after 4,120 km of running (t5), green: TLT, red: SAT
(=SAST + ABM), yellow: VAT + INF. ABM, adipose bone marrow; INF,
intraluminal nutrition fat; MRI, magnetic resonance imaging; SAST,
somatic adipose soft tissue; SAT, somatic adipose tissue; TEFR09,
Transeurope Footrace 2009; TLT, total lean tissue; VAT, visceral
adipose tissue.
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surements was preferred (only subjects who had the whole
body MRI at every measurement interval (t0 to t5): n = 12).
Therefore, a common linear model for repeated measure-
ments (with post hoc analysis on the significance between
the different times of measurement) was chosen. For cor-
rection of accumulation of the alpha level due to multiple
testing (of hypothesis: ‘The means at stage intervals are
significantly different to means at start’), the Bonferroni-Figure 2 Semiautomatic separation of somatic and visceral
volume (right row) and intraluminal nutrition fat (left row):
selected slices from whole body MRI of a 32-year-old male
finisher of TEFR09. V: hip/pelvis, VI: umbilical level, VII: upper
abdomen, VIII: heart/mediastinum. Left row: before start (t0), green:
SLT, red: TSAT, grey: TVV. Right row: after 4,120 km of running (t5),
green: TLT, red: SAT (=SAST+ABM), yellow: VAT, blue: INF. ABM,
adipose bone marrow; INF, intraluminal nutrition fat; MRI, magnetic
resonance imaging; SAT, somatic adipose tissue; SLT, somatic lean
tissue; TEFR09, Transeurope Footrace 2009; TLT, total lean tissue;
TSAT, total somatic adipose tissue; TVV, total visceral volume; VAT,
visceral adipose tissue.
Table 1 Abbreviations of compartments after tissue
mapping and segmentation with mobile whole body MRI
data sets (T2*)
Abbreviation Description, Definition
Tissue mapping in specific compartments
ABM Adipose bone marrow
TV Total volume of the body (from ankle to wrist),
without INF
TVV Total visceral volume: includes intrathoracic and
intraabdominal volume.
TSV Total somatic volume (TV without TVV).
TLT Total lean tissue
VLT Visceral lean tissue: includes lean tissue of intrathoracic
and intraabdominal organs.
SLT Somatic lean tissue: mostly muscles
TAT Total adipose tissue (without INF)
SAT Somatic adipose tissue (TAT without VAT)
TAST Total adipose soft tissue (TAT without ABM)
SAST Somatic adipose soft tissue (TAT without ABM and VAT)
SCAT Subcutaneous adipose tissue (SAST without IMAT)
IMAT Intermuscular adipose tissue (SAST without SCAT)
VAT Visceral adipose tissue (IAAT + MAT without INF)
IAAT Intraabdominal adipose tissue: retroperitoneal and
intraperitoneal (mesenteric, omental) fat depots
(without INF)
MAT Intrathoracic, mainly mediastinal adipose tissue
INF (Undigested) intraluminal nutrition fat in the
gastrointestinal tract
Tissue mapping of body segments
TV-LE Total volume of lower extremities (apex trochanter
major to ankle joint)
TV-TR Total volume of trunk (acromion to apex of
trochanter major)
TV-UE Total volume of upper extremities (wrist to acromion
level)
LT-LE Lean tissue volume of lower extremities
(apex trochanter major to ankle joint)
LT-TR Lean soft tissue volume of trunk (acromion to apex of
trochanter major)
LT-UE Lean soft tissue volume of upper extremities
(wrist to acromion level)
SAST-LE Adipose soft tissue volume of lower extremities
(apex trochanter major to ankle joint)
SAST-TR Adipose soft tissue volume of trunk (acromion to apex
of trochanter major)
SAST-UE Adipose soft tissue volume of upper extremities (wrist to
acromion level)
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plied. For the univariate ANOVA model, one precondition,
the sphericity of data (homogenity between the variance of
differences of two measurements) is necessary and was
proven by the Mauchly-Test. Because of the small numberof subjects, the power of the Mauchly-Test regarding spher-
icity is low. Therefore, the ‘Greenhouse-Geisser’ (SPSS)
correction procedure was used. Looking at result reliability
and test power, in cases of severe injury of the sphericity as-
sumption, a multivariate ANOVA test was used. In cases of
missing values, the specific dependent variable (specific
tissue compartment) was excluded from ANOVA analysis.
Analyses of difference
For dependence analysis including all stages of and total
TEFR09, analyses of difference between the dichotomous
nominally scaled dependent variables of the sample
finishing status (finisher/non-finisher: F/NF) regarding
prerace running performance history and regarding total,
lean and adipose tissue volumes were carried out.
Depending on normal or free distribution of the inde-
pendent interval scaled variables, the parametric inde-
pendent t-test (variance homogeneity was calculated with
Levene`s test) or nonparametric Mann–Whitney-U-test
was used. Due to the higher power in small cohorts, the
Shapiro-Wilk [27,28] test (and not the Kolmogorov-
Smirnov statistic [29]) was used to check for normal
distribution of the independent prerace variables of per-
formance (PRY, PRT, PRR).
Analysis of relationships
For analyses of relationships, the Pearson correlation coef-
ficient (CCP) and Spearman-rho correlation coefficient
(CCS) were calculated for parametric and non-parametric
parameters, respectively, using bivariate (two-sided) or
univariate (one-sided) testing as appropriate:
– BM versus TV and its distribution throughout the
race: bivariate CCS
– Prerace performance versus percentage total, lean
and adipose volumes: univariate CCS / CCP
– Race performance versus percentage total, lean and
adipose volumes: univariate CCP
For interpretation of CC-values the effect size according
to Cohen (r = 1: low, r = 3: medium, r = 5: high) was used




Figure 3 shows the topographical mapping of changes of
lean and adipose tissue of a subject (male, 32 years, fin-
isher) with one of the largest decreases of SAST and VAT
during TEFR09. Runners often had discomfort or pain
after stage finishing, so the investigators tried to adapt
body positioning in the MR scanner to the athletes’
current problems to make it as comfortable as possible for
them. Therefore, a reliable and strictly standardized lying
Figure 3 Topography of lean and adipose tissue changes in a 32-year-old male finisher.
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measurement. Sometimes, knees or elbows were positioned
more or less straightened. This explains the sometimes vis-
ible but small topographical phase shifting between differ-
ent times of measurement in Figure 3.Total body volume versus body mass/body mass index
The absolute volumes of all investigated body tissue com-
partments and segments are shown in Table 2. Over all
subjects, mean loss of BM and BMI at the end of the race
was 5.23 kg (SD 3.72 kg) and 1.49 kg/m2 (SD 1.18 kg/m2),
respectively (Tables 3 and 4). There was a high correlation
(CCS: 0.978, P <0.001) between BM (kg) and TV [1] regard-
ing mean absolute value changes throughout the race
(Figure 4).Percentage body composition
At the start of the TEFR09, the mean percentage volume
of TSV was 84.8 (SD 1.36 vol.%). TSV could be differen-
tiated into mean SLT 65.0 vol% (SD 5.33 vol%), mean
ABM 3.2 vol% (SD 0.89 vol%) and mean SAST 16.6 vol%
(SD 5.58 vol%). The mean TVV of 15.2 vol% (SD 1.36
vol%) is consistent and divides into mean VLT 12.3 vol%
(SD 1.23 vol%) and mean VAT 2.9 vol% (SD 1.37 vol%).
From these data the changes in mean vol% of tissue
compartments regarding the overall population of ultra-
runners could be calculated for transcontinental MSUM
races (Figure 5).
Total volumes
Percentage volume changes of TSV and TVV were not
significant (Table 3, Figure 6). For absolute volumes (TV,
Table 2 Mean volumes (l) of body compartments and segments (all subjects)
Abbreviation t0: start t1: 317 to 789 km t2: 1,003 to 1,635 km t3: 2,516 to 2,738 km t4: 3,234 to 3,669 km t5: 4,037 to 4,440 km
Tissue mapping in specific compartments
TV 57.70 56.63 54.75 53.39 54.16 52.65
TVV 8.74 8.34 7.93 7.64 7.65 7.58
TSV 48.97 48.29 46.82 45.74 46.51 45.08
TLT 44.34 44.61 45.07 45.38 46.20 45.52
VLT 7.02 7.04 7.01 7.10 7.14 7.12
SLT 37.32 37.56 38.06 38.28 39.06 38.40
TAT 13.36 12.02 9.68 8.00 7.96 7.14
SAT 11.65 10.73 8.76 7.46 7.45 6.68
TAST 11.52 10.19 7.76 6.05 6.01 5.19
SAST 9.81 8.89 6.84 5.51 5.50 4.73
VAT 1.71 1.30 0.92 0.54 0.51 0.45
IAAT 1.55 1.15 0.77 0.39 0.36 0.33
MAT 0.17 0.15 0.15 0.15 0.14 0.13
INF 0.05 0.21 0.36 0.57 0.70 0.86
ABM 1.98 1.93 1.92 1.95 1.95 1.95
Tissue mapping of body segments
TV-LE 23.51 22.49 21.46 21.65 22.02 20.60
TV-TR 28.83 28.63 27.86 26.57 27.03 27.00
TV-UE 5.79 5.89 5.75 5.73 5.64 5.60
TLT-LE 17.51 16.97 16.82 17.45 17.83 16.97
TLT-TR 23.22 23.12 23.46 23.02 23.39 23.39
TLT-UE 4.79 4.62 4.70 4.81 4.74 4.77
SAST-LE 4.84 4.36 3.43 2.96 2.96 2.40
SAST-TR 4.31 3.47 2.12 1.02 0.99 0.81
SAST-UE 0.98 0.95 0.72 0.57 0.54 0.48
ABM, adipose bone marrow; IAAT, intraabdominal adipose tissue; INF, intraluminal nutrition fat; LE, lower extremities; MAT, mediastinal adipose tissue; SAST,
somatic adipose soft tissue; SAT, somatic adipose tissue; SLT, somatic lean tissue; TAT, total adipose tissue; TLT, total lean tissue; TR, trunk; TSV, total somatic
volume; TV, total volume; TVV, total visceral volume; UE, upper extremities; VAT, visceral adipose tissue; VLT, visceral lean tissue.
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uated with a very high test power (Table 5). Except for
TSV at the first measurement interval, significant de-
creases for TV, TSV and TVV could be shown at all MIs
throughout TEFR09 (Figure 7). Paired comparison of MI
after the start showed no significant difference for TVV
but partial differences for TV and TSV (Figure 7).
Total volume
After more than 4,000 km of running the mean TV showed
a mean decrease of 9.5% (SD 5.1%, min −2.7%, max −17.9%)
compared to the start. Depending on the total sample the
mean TV decrease for the overall population of ultra-
runners ranges between 8% to 11% (SE 1.5%), (Figure 8).
Looking only at the group of finishers, the absolute amount
of mean TV loss at the last MI was 6.1 L (SD 3.4 L, min−2.5
L, max −12.6 L (Figure 9). Mean loss of TV per km was 3.5
ml (SD 2.9 ml/km) in the beginning and became smaller, likea reversed parabolic function, during TEFR09 down to 1.5
ml/km (SD 0.8 ml/km) at the end of the race (Figure 10).
Total somatic volume
The relative decrease of TSV during TEFR09 showed a
nearly similar curve as TV (Figure 8), but was less pro-
nounced (mean −9.4% after more than 4,000 km, SD 5.3%,
min −2.1%, max −18.1%) with the same SE of 1.5%. For
the finisher group the absolute loss of TSV increased to
5.2 L in the mean (SD 3.0 L, min −1.7 L, max −11.1 L) at
the end of the race (Figure 9). This is consistent with a
mean TSV loss of 1.3 ml/km (SD −0.7 ml/km) at the end
of TEFR09, starting with 2.7 ml/km (SD 2.7 ml/km) in the
first eight stages of TEFR09 (Figure 10).
Total visceral volume
Compared to TV and TSV, the relative decrease of TVV
occurred much faster but ended in a nearly similar
Table 3 BM and BMI loss during TEFR09
Number Distance BM (kg) BMI (kg/m2)
all F NF run (km) all F NF all F NF
mean mean SD mean SD mean SD mean SD mean SD mean SD
22 12 10 0.00 71.75 11.13 72.07 11.23 71.38 11.60 23.58 2.55 23.36 2.58 23.84 2.62
15 10 5 116.1 72.43 10.82 71.38 12.48 74.54 7.14 23.33 2.47 22.98 2.75 24.02 1.87
20 11 9 354.2 70.53 11.67 72.20 11.63 68.49 12.07 23.18 2.68 23.26 2.58 23.08 2.95
21 12 9 618.5 70.20 11.20 70.51 11.04 68.08 12.22 22.98 2.59 22.84 2.35 22.95 3.07
20 12 8 893.8 68.73 10.96 70.04 10.60 66.76 11.92 22.68 2.51 22.70 2.23 22.67 3.05
17 12 5 1,168.2 69.52 10.65 69.83 10.78 68.76 11.56 22.72 2.31 22.62 2.23 22.96 2.77
16 12 4 1,456.9 68.18 10.72 68.93 10.70 65.93 12.09 22.20 2.21 22.33 2.25 21.80 2.35
15 12 3 1,754.0 68.39 10.61 68.65 10.45 67.37 13.59 22.26 2.08 22.24 2.12 22.38 2.34
15 12 3 2,026.1 67.64 10.93 67.94 10.57 66.43 14.78 22.01 2.18 22.01 2.19 22.02 2.65
14 11 3 2,294.2 68.01 10.81 68.19 10.75 67.37 13.47 22.11 2.13 22.03 2.18 22.39 2.35
14 12 2 2,594.5 67.05 10.83 67.44 10.30 64.70 18.53 21.73 2.05 21.85 2.18 20.98 0.81
14 12 2 2,852.0 68.88 9.85 67.66 10.14 76.20 2.12 22.17 2.19 21.92 2.09 23.69 3.06
13 12 1 3,134.2 68.45 9.95 67.73 10.04 77.00 21.90 1.95 21.95 2.03 21.33
13 12 1 3,401.7 68.58 10.07 67.78 10.06 78.30 21.93 1.91 21.95 1.99 21.69
12 12 3,724.8 67.35 10.16 67.35 10.16 21.82 2.15 21.82 2.15
12 12 4,010.8 67.48 9.91 67.48 9.91 21.87 2.06 21.87 2.06
12 12 4,307.3 66.83 10.50 66.83 10.50 21.64 2.12 21.64 2.12
BM,body mass; BMI, body mass index; F, finisher; NF, non-finisher; TEFR09, Transeurope Footrace 2009.
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max −19.3%) in a negative parabolic graph shape (see
Figure 8). The mean loss of absolute TVV was 0.9 L (SD
0.5 L, min −0.3 L, max −1.7 L) for finishers (Figure 9).
Mean absolute TVV loss per km during TEFR09 had a
maximum of 0.75 ml/km (SD 0.5 ml/km) at the beginning
and 0.2 ml/km (SD 0.1 ml/km) at the end (Figure 10).
Adipose tissue
In total (TAT), somatic (SAST) and visceral (VAT) adipose
tissue, a significant change of absolute volumes (Table 5)Table 4 Significance of topographic tissue volume changes re
Mauchly-Test Univariate ANOVAb
(vol.%) P-value F value P value
TSV 0.322 2.565 0.058
TVV 0.322 2.565 0.058
TLTa 0.000 44.605 0.000
SLTa 0.000 43.573 0.000
VLTa 0.005 22.980 0.000
TATa 0.000 44.655 0.000
SASTa 0.000 44.721 0.000
VATa 0.000 23.718 0.000
amean differences are significant; b‘Greenhouse-Geisser’ correction procedure was u
of Roy’. ANOVA, analysis of variance; SAST, somatic adipose soft tissue; SLT, somatic
volume; TVV, total visceral volume; VAT, visceral adipose tissue; VLT, visceral lean tis
Bold numbers mark the prefered P-value of the prevered ANOVA regarding sphericand percentage volumes (Table 3) could be evaluated with
a very high test power at the different MIs during TEFR09.
A significant decrease for TAT, SAST and VAT could be
shown at all MIs throughout TEFR09 compared to the
start and for TATand SAST compared to the first MI after
the start (stage 5 to 12) (Figure 11). For other MIs the
paired comparison showed no significant change.
Total adipose tissue
There was a continuous decrease of TAT that ended in
a relative mean loss of 41.3% (SD 8.0%, min −25.4%,garding percentage volume (vol. %)
Multivariate ANOVAc
test power F value P value test power
0.640 - - -
0.640 - - -
1.000 51.592 0.000 1.000
1.000 19.556 0.001 1.000
1.000 6.699 0.013 0.884
1.000 52.762 0.000 1.000
1.000 57.109 0.000 1.000
1.000 8.598 0.007 0.950
sed; cPillai-Spur, Wilks-Lambda, Hotelling-Spur and ‘biggest characteristical root
lean tissue; TAT, total adipose tissue; TLT, total lean tissue; TSV, total somatic
sue.
ity assumption proven by Mauchly-Test.
Figure 4 Comparison of total body volume versus body mass
during TEFR09 (finisher, nF = 12). TEFR09, Transeurope
Footrace 2009.
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http://www.biomedcentral.com/1741-7015/11/122max −53.2%) with a small SE of 2.3% (Figure 8) at the
last MI. Looking at the absolute loss of TAT, a finisher
lost 5.3 L in the mean (SD 2.6 L min −2.7 L, max −9.8 L)
until the end of the race (Figure 9). The mean TAT loss
per km in finishers was 3.2 ml (SD −1.7 ml/km) at the be-
ginning and 1.2 ml (SD 0.6 ml/km) at the end of TEFR09
(Figure 10).
Somatic adipose soft tissue
The relative SAST decrease compared to the start
showed a steeper graph than TAT and ended in a mean
loss of 48.7% (SD 9.9%, min −25.9%, max −65.5%) after
more than 4,000 km (Figure 8). The absolute SAST de-
crease in finishers showed a mean of 4.4 L (SD 2.2 L,
min −2.2 L, max −8.4 L) at the end of TEFR09 (Figure 9).
This corresponds to a mean loss of SAST of 1.1 ml/km
(SD 0.5 ml/km) at the end of TEFR09 compared to 2.4
ml/km (SD 1.4 ml/km) at the start (Figure 10).
Visceral adipose tissue
The relative decrease of VAT occurred much more rap-
idly in the mean and ended in a relative VAT volumeFigure 5 Adipose and lean volume percentage distribution in
finishers at the start and end of TEFR09 (finisher, nF = 12).
TEFR09, Transeurope Footrace 2009, SE is indicated in brackets.loss of 64.5% (SD 15.9%, min −27.7%, max −88.8%) at
the end of the race (Figure 8) compared to the start and
a SE up to 4.6%. The percentage volume of VAT de-
creased more quickly and severely compared to absolute
VAT volume (Figure 12). In absolute values, this rapid
and continuous loss of VAT ended in a mean of −0.9 L
(SD 0.5 L, min −0.3 L, max −1.7 L) in the finisher group
(Figure 9), which was nearly the same as the absolute
TVV loss. Therefore, the mean VAT volume loss per km
was the same as for TVV in the finishers (Figure 10).
The subdivision of VAT into IAAT and MAT shows that
IAAT decreased a bit faster than VAT in total and ended
in a relative volume loss of 67.3% (SD 14.8%, min −31.7%,
max −88.8%) at the end (Figure 13). MAT initially de-
creased as rapidly as IAAT with respect to VAT but
reached a plateau of 30% volume loss after nearly 1,000
km of running before it decreased again in the last third
of the race up to 41.5% with a larger variance (SD 24.7%,
min −0.1%, max −89.0%).
Lean tissue
Due to significant and continuous loss of different adi-
pose tissue volumes the percentage volume of TLT, SLT
and VLT increased during TEFR09 significantly without
relevant changes in absolute volumes, respectively
(Table 3, Figure 12); analysis of the means of absolute
volume showed no significant changes for total, somatic
and visceral lean tissue at the different MIs during
TEFR09 (Table 5).
Total lean tissue, somatic lean tissue, visceral lean tissue
TLT volume showed undulating relative changes
duringTEFR09 in the mean compared to the start. Just
at the end, after more than 4,000 km running, the mean
relative changes were −1.2% TLT (SD 3.3%, min 6.3%,
max −5.5%) with an SE of 1.0% (Figure 8). Due to nearly
stable volume regarding VLT during TEFR09, the SLT
data during TEFR09 was similar to that of TLT relative
to the start: mean −1.4% (SD 3.9%, min 7.5%, max −6.6%).
Not every finisher showed a decrease of absolute TLT and
SLT; some of them showed increases, some decreases:
mean −0.9 l (SD 1.2 L, min 1.1 L, max −2.8 L); see Figure 9.
Mean loss of TLT and SLT per km changed between 0.3
and 0.2 ml with a wide range (SD at beginning 1.9 ml/km,
at the end 0.3 ml/km), see Figure 10.
Segmental volume analysis
The significance of the volume changes in the different
body segments is shown in Table 6. For the lower ex-
tremities the change of volumes was only significant for
SAST_LE but not for TV_LE or LT_LE; for the trunk
and upper extremities decreases were significant for adi-
pose soft tissue volume (SAST_TR, SAST_UE) and total
volume (TV_TR, TV_UE) but not for lean tissue volume
Figure 6 Changes of somatic and visceral percentage volumes during TEFR09 (finisher, nF = 12). TEFR09, Transeurope Footrace 2009.
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http://www.biomedcentral.com/1741-7015/11/122(LT_TR, LT_UE). Most decrease of somatic adipose tis-
sue occurred in the trunk (t5: mean −50.3%, SD 12.0%),
followed by the arms (t5:mean −39.1%, SD 8.3%); in the
legs the adipose tissue lose was the smallest, but signifi-
cant (t5: mean −29.2%, SD 13.4%), Figure 14. Although
changes of lean tissue were not significant in any seg-
ment, mean values demonstrate a mean increase in the
legs in the first half of TEFR09, and in the trunk in the
first third of the race, while in the arms lean tissue loss
was already detectable at the first MI t1 (Figure 14).
Finisher/non-finisher
A total of 45.5% of the subjects did not finish the race. The
dropout rate of subjects compared to all race participants
is shown in Figure 15. The main reason (70%, ni = 7) for
premature dropping out of the race was intolerable pain in
the legs due to an overload of muscle and tendons (softTable 5 Significance of topographic tissue volume changes re
Mauchly-Test Univariate ANOVAb
(l) P value F value P value
TVa 0.000 20.162 0.000
TSVa 0.001 18.607 0.000
TVVa 0.000 21.516 0.000
TLT 0.516 1.209 0.322
SLT 0.516 1.209 0.322
TATa 0.000 32.274 0.000
SASTa 0.000 32.692 0.000
VATa 0.000 21.607 0.000
amean differences are significant; b‘Greenhouse-Geisser’ correction procedure was u
of Roy.’ ANOVA, analysis of variance; SAST, somatic adipose soft tissue; SLT, somatic
volume; TVV, total visceral volume; VAT, visceral adipose tissue.
Bold numbers mark the prefered P-value of the prevered ANOVA regarding spherictissues) leading to intermuscular and peritendinous inflam-
mation (fasciitis): lower legs (40%), upper legs (30%). Other
reasons were a high tibial stress fracture, a painful bunion
and one rapidly progressing phlegmonia from the thumb
up to the forearm needing immediate surgical intervention.
Figure 16 shows the distribution of percentage
volumes for all tissue compartments at the start time
(t0) and MI t1 (317 to 789 km) for finishers (nF = 12)
and non-finishers (nNF = 10) of TEFR09. At both times
the finisher group had significantly more percentage
volume regarding total somatic tissue (mean TSV) than
non-finishers of TEFR09 (at t0 +1.8%: 85.5 vol% versus
84.0 vol%, at t1 +1.6%: 85.8% versus 84.4%) and, there-
fore, significantly less percentage volume of mean TVV
(at t0 -10.5%: 14.5 vol% versus 16.0 vol%, at t1 -9.5%: 14.2
vol% versus 15.6 vol%), Table 7. The finisher group
showed significantly less adipose tissue volume percentagegarding absolute volume measurements (l) (nF = 12)
Multivariate ANOVAc
test power F value P value test power
0.999 5.758 0.020 0.828
0.999 4.937 0.030 0.762
0.999 8.678 0.007 0.952
0.307 - - -
0.307 - - -
1.000 18.577 0.001 1.000
1.000 15.624 0.001 0.998
0.999 8.594 0.007 0.950
sed; cPillai-Spur, Wilks-Lambda, Hotelling-Spur and ‘biggest characteristical root
lean tissue; TAT, total adipose tissue; TLT, total lean tissue; TSV, total somatic
ity assumption proven by Mauchly-Test.
Figure 7 Post hoc analysis of significance of paired comparison of total volume measurements at different time intervals (finisher, nF = 12).
Schütz et al. BMC Medicine 2013, 11:122 Page 12 of 27
http://www.biomedcentral.com/1741-7015/11/122than the non-finishers for TAT and VAT at t0 and t1, and
also for SAST at t1 (Table 7). At the start, non-finishers
had 71.5% more VAT volume percent (mean VAT at t0:
2.2 vol% versus 3.8 vol%), 28.0% more SAST volume per-
cent (mean SAST at t0: 15.0 vol% versus 19.2 vol%) and in
total 26.6% more TAT volume percent (mean TAT at t0:
20.6 vol% versus 26.1 vol%) than the finishers (Table 7). At
the first MI, t1, the difference between finisher and non-
finisher was significantly further on; non-finishers had
96.8% more VAT volume percent (mean VAT at t0: 1.6
vol% versus 3.2 vol%), 39.7% more SAST volume percent
(mean SAST at t0: 13.3 vol% versus 18.5 vol%) and in total,
34.9% more TAT volume percent (mean TAT at t0: 18.3
vol% versus 24.7 vol%) than finishers (Table 7). These dif-
ferences for adipose tissue compartments were no longer
detectable as the race proceeded (t2 to t5); either there are
not enough numbers to treat in the group of non-finishers
for further analysis on the difference with finishers or no
difference could be shown. Conversely, the lean tissue dif-
ference of percentage volume was significantly smaller in
non-finishers compared to finishers for TLT (at t0: -6.9%,
at t1: -7.8%) and SLT (at t0: -8,1%, at t1: -8.9%) (Table 7).
VLT showed no significant difference between finishers and
non-finishers at any MI (t0 to t5). Table 8 and Figure 17
demonstrate a significant relative volume loss at MI t1 and
t2 compared to the start only for SAST and no other tissue
compartment.
Prerace performance
Although there is a wide range of finished long distance
foot races in the subject group (Table 9), everyparticipant of TEFR09 had already finished nearly one
UM and MSUM, but not every subject had finished a
single marathon. The endurance training extent of one
year and three months before TEFR09 also varied for train-
ing volume (km), time (hours) and intensity (km/hour) in
the subject group (Table 9). For the number of finished
marathons, UM and MSUM no difference between finisher
and non-finisher could be evaluated (Table 10). However,
regarding prerace training volume and intensity one year
before TEFR09 and their 50 km- and 24 hour-race record,
finishers had a significantly higher prerace-performance
compared to non-finishers (Table 10). Only these five
prerace-performance parameters (PRTVol08, PRTVol09,
PRTInt08, PRR50km, PRR24hr) also showed a mainly high and
medium correlation with the volume percentage of adipose
tissue compartments (VAT, SAST, TAT), TLT and SLT
(Figure 18).
Race-performance
No relevant correlation between percentage fat and lean
volumes of different compartments at the start and the
race performances of the subjects at TEFR09 could be
detected (Figure 19). For SAST at the beginning of
TEFR09 (stage 1 to 8) a significant correlation between
percentage volume at the start and cumulative perform-
ance is given, but only at a medium to low effect size.
For TAT, TLT and SLT the significance for such a correl-
ation is shown at the first 12 to 15 stages and during the
last third of TEFR09 at a medium effect size (Figure 19).
A correlation of percentage fat and lean volumes to per-
formance at the individual stages can only be shown for
Figure 8 Mean and standard error of relative changes of specific tissue volume during TEFR09 compared to the start (total sample,
n = 22). TEFR09, Transeurope Footrace 2009.
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tive changes in the investigated volumes duringTEFR09
were significantly correlated with performance.
Discussion
Almost nothing is known about the influence of the en-
durance burden on the specific changes in body com-
position regarding distribution of adipose and lean
tissues in somatic and visceral compartments and in the
body segments. Field studies on this topic mostly use
methods which only allow indirect measurements and
approximated calculations or simple estimations of totalor local adipose or lean tissue proportions [11-14]. For
TAT and subcutaneous adipose tissue (SCAT = SAST
without intermuscular adipose tissue (IMAT) [31]),
some of these indirect methods show more or less cor-
relation to MRI findings [17]. These methods are not
able to predict the amount of visceral (VAT) or somatic
adipose tissue (SAT) in the body [16,32]. Being the first
investigation in endurance field studies using the gold
standard method [18] whole body MRI for such ana-
lyses, our results provide new data on the volume
changes of fat and lean tissue in these different parts of
the athlete’s body.
Figure 9 Absolute changes of specific tissue volume during TEFR09 compared to the start (finisher, nF = 12). TEFR09, Transeurope
Footrace 2009.
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Bale et al. [33] found a lower percentage of body fat in fe-
male elite marathon runners. In obese patients (BMI >27
kg/m2) Machann et al. [25] found that the amount and dis-
tribution of adipose tissue correlated with age (VAT in-
creasing with age) and with gender (%SAT female > male, %
VAT male > female). They found no consistent differences
in TAT profiles between the selected age groups for both
females (n = 40, mean age 45 years, SD 12 yrs., range 23 to
64 yrs.) and males (n = 40, mean age 45years SD 12 yrs.,range 24 to 65 yrs.) in their group. Naturally, our group of
ultra-runners with a comparable age distribution (n = 22,
mean age 49 years, SD 12 years, range 27 to 69 years)
showed a very low absolute mean volume of VAT at the
start of TEFR09 (females: 0.5 L, males 1.8 L) compared to
obese patients (females 1.5 to 4 L, males 4 to 6.8 L) [25].
Statistical analysis of gender-related differences was not
possible (only two females) in our group, but even these
data indicate that a difference in VAT between men and
women is not only visible in obese people, but is also visible
Figure 10 Absolute volume changes per km compared to the start in the finisher group (finisher, nF = 12). TEFR09, Transeurope
Footrace 2009.
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showed no correlation to fat distribution at the start (TAT,
SAST, VAT) or to volume changes of lean and adipose
tissue during TEFR09.
Changes in body composition
Different effects of endurance performance on body com-
position are described in the literature. Beyond dispute is
the fact that endurance performance leads to a decrease in
body mass, mainly body fat. Body fat is the main energy-
rich substrate for endurance performance [34-37]. There-
fore, endurance exercise leads to a reduction ofsubcutaneous tissue as demonstrated in several field stud-
ies [34,36,38].
The specific influence on energy turnover seems to de-
pend on the type of endurance burden [1,39]. In general,
non-stop ultra-endurance races over hours, days or
weeks without a break result in a decrease in body mass
[1,36,40,41] in which body fat as well as skeletal muscle
seems to decrease [1,36,40-42]. In ultra-endurance per-
formances with defined breaks, body mass may remain
stable [43-45] or even increase [34] and body fat is
reduced [34,46,47], whereas skeletal muscle mass seems
to be spared [35,43,47] or may even increase [46]. Our
Figure 11 Post hoc analysis of the significance of the paired comparison of total fat tissue measurements at different time intervals
(finisher, nF = 12).
Figure 12 Changes of adipose and lean tissue percentage volumes during TEFR09 (finisher, nF = 12). TEFR09, Transeurope Footrace 2009.
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Figure 13 Relative changes of visceral adipose volume during
TEFR09 compared to the start (total sample, n = 22). TEFR09,
Transeurope Footrace 2009.
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ultra-long MSUM over 64 days without any day rest;
every subject decreased in BM(I), TV, TSV and TVV due
to massive loss of TAT, SAT and VAT, respectively. Not
every runner lost TLT and SLT during the TEFR09.
Some of them showed increases, some decreases.
Knechtle at al. found the same individual differences for
lean tissue in ultra runners during a 1,200 km MSUM
across Germany [48]. If there are not sufficiently long
breaks in ultra-endurance races, some participants might
not find enough time for regeneration and restoration of
their energy depots before the next stage. As the race
progresses this leads to the utilization of muscle tissue
for energy provision.Table 6 Significance of segmental volume changes regarding
Mauchly-Test Univariate ANOV
(l) P value F-value P value
TV_LE 0.003 7.763 0.002
TV_TRa 0.133 6.349 0.003
TV_UEa 0.001 27.504 0.000
SLT_LE 0.003 6.411 0.20
SLT_TR 0.252 3.534 0.21
SLT_UE 0.700 3.128 0.29
SAST_LEa 0.000 63.294 0.000
SAST_TRa 0.000 17.388 0.000
SAST_UEa 0.000 16.151 0.000
TV_LEa 0.001 27.504 0.000
TV_TRa 0.133 6.349 0.003
TV_UE 0.003 7.763 0.002
amean differences are significant; b‘Greenhouse-Geisser’ correction procedure was u
of Roy’. ANOVA, analysis of variance; LE, lower extremities; SAST, somatic adipose so
upper extremities.
Bold numbers mark the prefered P-value of the prevered ANOVA regarding sphericMass loss
Raschka and Plat observed a mean loss of 1.75 kg body
mass in an ultra-endurance run over 1,000 km within 20
days [34]. In their investigation, there was a statistically
significant decrease in body mass after day 8 until day
11, which then remained stable until the finish. In an-
other investigation of 10 ultra runners (BIA), the mean
loss of BM after a 1,200 km footrace was also not signifi-
cant, but the loss of 3.9 kg fat mass was [48]. Unfortu-
nately, the authors gave no information about the
relative changes of fat and lean body mass. Our results
determined that a transcontinental ultra-long MSUM of
64 stages leads to a significant three times higher loss of
body volume (9.5%) than published for body mass loss
in deca-triathlons or 20 stage MSUMs [34,47].
The relation of water and lipid to the density of
human adipose tissue ranges from 0.925 to 0.97 kg/L
[49]. Assuming the middle value (0.948 g/L), in our in-
vestigation the ultra-athletes lost a total fat mass (TAT)
of 4.8 kg in the mean (SAST 4.0 kg, VAT 0.8 kg), resem-
bling the main part (91.8%) of body mass loss of 5.2 kg.
The lean tissue of the human body has a higher density than
adipose tissue and muscle tissue (range 1.05 to 1.06 g/L)
and varies with age [49,50], ranging between 1.10 and
1.11 g/L [51,52]. With these data and knowing the
mean relative reduction of TLT (1.2%), the mean loss of
lean body mass can be calculated as about −0.67 kg at
the end of TEFR09 in our subject group.
Visceral adipose tissue
Mediastino-abdominal lipomatosis is described as be-
ing associated with exertional dyspnea [53], non–insu-
lin-dependent diabetes, type IV hyperlipidemia, andrepeated absolute volume (l) measurements (nF = 12)
Ab Multivariate ANOVAc
test power F-value P value test power
0.946 2.341 0.149 0.423
0.918 - - -
1.000 13.942 0.002 0.996
0.733 14.587 0.095 0.597
0.769 - - -
0.734 - - -
1.000 20.644 0.000 1.000
0.996 13.387 0.002 0.995
0.987 3.389 0.041 0.584
1.000 13.942 0.002 0.996
0.918 - - -
0.946 2.341 0.149 0.423
sed; cPillai-Spur, Wilks-Lambda, Hotelling-Spur and ‘biggest characteristical root
ft tissue; SLT, somatic lean tissue; TR, trunk; TV, total volume; UE,
ity assumption proven by Mauchly-Test.
Figure 14 Relative changes of segmented tissue volume (UE, TR, LE) during TEFR09 compared to the start (finisher, nF = 12). LE, lower
extremities; TEFR09, Transeurope Footrace 2009, TR, trunk; UE, upper extremities.
Schütz et al. BMC Medicine 2013, 11:122 Page 18 of 27
http://www.biomedcentral.com/1741-7015/11/122hyperuricemia. The abdominal VAT is an important inde-
pendent risk factor for metabolic diseases in the older pa-
tient [54] and there is evidence that mainly abdominal
VAT, which is morphologically and functionally different
from abdominal SAST, is associated with the metabolic
syndrome (insulin resistance, dyslipidemia, hypertension,
obesity) and hyperinsulinemia [55-60], as well as linked in-
flammatory diseases [61]. The real mean loss of relative
IAAT while running a MSUM of nearly 4,500 km, wasmore than two thirds compared to the start in our group
(Figure 13). We showed that endurance running also has
an direct influence on intrathoracic fat, especially MAT,
which decreased up to more than 40% in the mean
(Figure 13). MAT is associated with hypertension, obes-
ity, and iatrogenic Cushing syndrome [57,62-65].
Until now, a specific treatment for the selective reduc-
tion of VAT is not known [66] and as our MR analyses
showed that VAT decreased much more rapidly and
Figure 15 Dropout rate.
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ive way to reduce the risk of metabolic disease is endurance
running. As VAT decreases much faster and more than
SAST, our investigation indicates that three-compartment
measurement methods, such as SF-analyses and BIA, can-
not give accurate assumptions or calculations for IAAT and
MAT. Even the results of the four-compartment method
cadaver study are false, when post mortem findings are
transferred to physiological effects which occur from the
impact of long lasting running on fat and lean tissue
in vivo [67].
Finishers versus non-finishers
55% (n = 12) of the 22 ultra-runners treated with mobile
whole body MRI for this study reached the last measure-
ment interval; 10 dropped out earlier. In contrast, the
dropout rate for all starters at TEFR09 and all subjectsFigure 16 Difference between F and NF regarding percentage tissue
measurement interval; NF, non-finisher; TEFR09, Transeurope Footrace 2009taking part in the TEFR project was 31% [2]. Reasons for
dropping out of this transcontinental MSUM race were
overuse reactions of the musculoskeletal system of the
lower extremities (80%, Figure 15), mainly concerning
the myotendinous fascial system.
In a 17-day MSUM (1,200 km) Knechtle et al. found
no differences between finishers and non-finishers
regarding the anthropometric parameters, BMI, SF, CF,
estimated skeletal muscle mass (estimated from SF and
CF) and percent body fat (BIA) [68]. With whole body
MRI for differentiated body composition analysis, how-
ever, we found significant differences between finishers
and non-finishers between both somatic and visceral
volumes and between adipose and lean tissue volumes at
the start and early beginning of the 4,500 km MSUM
TEFR09 (Figure 16). Out results indicate that the risk of
dropping out of such an ultra-long transcontinental foot-
race is significantly higher when the total body fat per-
centage is more than 21% to 25% at the start, in which
the visceral fat percentage (VAT) shows a higher differ-
ence between finishers and non-finishers (71.5% in the
mean) than the somatic fat compartment (SAST, 28.0%).
Because VAT is affected by the endurance running bur-
den most quickly and most deeply compared to somatic
fat and other lean tissue (Figure 9) and is highly corre-
lated with prerace performance regarding training
volume and intensity and specific ultramarathon race-
performance (50 km-race), our results indicate,that VAT
is the most sensible predictor for the risk of non-
finishing a transcontinental MSUM, such as the TEFR09.
In ultra-runners there is not a high SAST or TAT, if the
VAT is low.
Although training a distance of 4,500 to 5,000 km is
not possible, participants of such MSUMs shouldvolumes before the start of TEFR09 and at MI t1. F, finisher;
.
Table 7 Analysis of the difference of percentage volume (vol%) between F/NF at the start (t0) and MI (t1, t2) for total,
lean and adipose tissue compartments
t0: nF = 12, nNF = 10 t1: nF = 12, nNF = 8 t2: nF = 12, nNF = 6












TSV 1.52 0.005a 1.35 0.036a 1.07 0.182
TVV −1.52 0.005a 1.35 0.036a 1.07 0.182
TLT 4.04 0.031a 6.39 0.015a 5.05 0.088
SLT 4.16 0.014a 6.18 0.010a 4.65 0.058
VLT 0.032 0.953 0.21 0.707 0.39 0.604
TAT −5.47 0.031a −6.39 0.015a −5.04 0.088
SAST −4.21 0.080 −5.27 0.032a −3.64 0.184
VAT −1.60 0.006a −1.56 0.021a −1.46 0.060
amean differences between finishers and non-finishers are significant. t0: at start of TEFR09, t1: stage 5 to 12 (317–789 km), t2: stage 15 to 24 (1,003 to 1,635 km).
F, finishers; ITT, t-test for independent samples; MI, magnetic imaging; NF, non-finishers; SAST, somatic adipose soft tissue; SLT, somatic lean tissue; TAT, total
adipose tissue; TERF09, Transeurope Footrace 2009; TLT, total lean tissue; TSV, total somatic volume; TVV, total visceral volume; VAT, visceral adipose tissue; VLT,
visceral lean tissue.
Bold numbers mark significant P-values.
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composition and performance skills even before the race
if they want to have a good chance to finish: VAT near
20% to 21%, training volumes of more than 100 km/
week one year before the race and the performance
intensity of 7.5 km/hour at a minimum allowing specific
ultra-race records of less than 5 hours in 50 km-races or
more than 178 km in 24-hour races. In other words, if
these levels of prerace performance are reached for at
least 15 months before the transcontinental race, the
VAT (and SAST, TAT) as the sensible marker for specific
body composition adaptation is also in an optimal rangeTable 8 Analysis of the difference in relative volume
changes (%) at MI t1 and t2 compared to start between
F/NF for total, lean and adipose tissue compartments









TV 0.47 0.608 −1.49 0.306
TSV 0.41 0.690 −2.06 0.190
TVV 0.69 0.640 1.35 0.410
TLT 1.09 0332 −0.18 0.913
SLT 1.34 0.319 −0.21 0.917
VLT 0.07 0.923 −0.24 0.545
TAT −4.86 0.086 −9.52 0.078
SAST −6.93 0.031a −14.27 0.046a
VAT −8.92 0.191 −8.88 0.276
amean differences between finishers and non-finishers are significant. F,
finishers; ITT, t-test for independent samples; measurement interval; NF, non-
finishers; SAST, somatic adipose soft tissue; SLT, somatic lean tissue; t0, at start
of TEFR09; t1,stage 5 to 12 (317 to 789 km); t2, stage 15 to 24 (1,003-1,635
km); TAT, total adipose tissue; TEFR09, Transeurope Footrace 2009; TLT, total
lean tissue; TSV, total somatic volume; TV, total volume; TVV, total visceral
volume; VAT, visceral adipose tissue; VLT, visceral lean tissue.
Bold numbers mark significant P-values.for low risk of non-finishing, because these parameters
correlate in a mostly high level.
Because the subjects mainly fall out of the race due to
overuse injuries in the myotendinous fascial system of
the lower extremities, we tend to assume that the men-
tioned interdependent parameters of body composition
and prerace ultra-running performance, lead to overuse
injuries in the main stressed musculoskeletal organs, if
they are not highly adapted as mentioned above; too
little specific ultra endurance adaption and too much of
VAT (and SAST) results in a high risk of severe soft tis-
sue overuse in the legs and mostly happens in the early
phase (Figure 15) of a transcontinental foot race.
Nearly every starter of TEFR09 showed, more or less
often, overuse soft tissue problems of the myotendinousFigure 17 Difference between F and NF regarding relative
volume changes of tissue compartments at first measurement
interval (t1) of TEFR09. F, finishers; NF, non-finishers; TEFR09,
Transeurope Footrace 2009.
Table 9 Endurance running history of subjects (n = 22)
Mean SD 95%-percentile Range
Years of regular endurance running 17.4 7.6 6.3 to 31.8 6 to 32
M finished (number) 123,1 218,2 2 to 297.8 2 to 988
UM finished (number) 90,8 68 11.3 to 248.9 11 to 255
MSUM finished (number]) 6,3 2,9 1.3 to 13.6 1 to 14
Endurance training extent 2008 (one year before TEFR)
Annual running distance (km/year) 5,468 1,720 3,000 to 9,000 2,580 to 9,152
PRT08 volume (km/week) 105.1 32.4 50.8 to 175.4 50 to 176
PRT08 time (hours/week) 12.5 3.1 7.1 to 19.6 7 to 20
PRT08 intensity (km/hour) 8.3 1.5 6.5 to 10.9 7 to 11
Endurance training extent last two months before TEFR
Total running distance ([km) 898 267 500 to 1260 500 to 1,500
PRT09 volume (km/week) 110.5 33.8 60.5 to 186 60 to 190
PRT09 time (hours/week) 13.2 3.5 8 to 21.6 8 to 22
M, marathon; MSUM, multistage ultramarathon; PR, prerace; TEFR, Transeurope Footrace; UM, ultramarathon.
Schütz et al. BMC Medicine 2013, 11:122 Page 21 of 27
http://www.biomedcentral.com/1741-7015/11/122fascial structures of the legs during the race, but the feet
are not a region for problems for experienced endurance
runners in a MSUM [69]. So the immense amount of
mechanical stress on the musculoskeletal system when
running nearly two marathons daily over a period of
nine weeks can lead to these overuse syndromes without
the obligatory necessity of prevalent (intrinsic) factors,
such as ‘overweight’ (high VAT), suboptimal ultra-Table 10 Distribution type and analyses of the difference bet
Values Mean
Valid Missing
n n (%) F
PRY (years) 21 1 4.5 16.5
nF M (n) 19 3 13.6 81.5
nF UM (n) 22 0 0 94.8
nF MSUM (n) 22 0 0 7.0
PRTVol08 (km/week) 21 1 4.5 117.9 (34.3)
PRTTime08 (hour/week) 21 1 4.5 13.0
PRTInt08 (km/hour) 22 0 0 9.0 (1.47)
PRTVol09 (km/week) 21 1 4.5 126.1 (35.2)
PRTTime09 (hours/week) 21 1 4.5 14.2
PRRM (hours) 15 7 31.8 3.1
PRR50km (hours) 9 13 59.1 4.3 (0.57)
PRR100km (hours) 17 5 22.7 9.5
PRR6hr (km) 13 9 40.9 67.9
PRR12hr (km) 10 12 54.5 99.9
PRR24hr (km) 16 6 27.3 199.8 (22.5)
aITT: independent t-test; bbilateral (asymptotic) test; csignificance not shown (P >0.0
non-finishers are significant. F, finishers; M, marathon; MSUM, multistage ultramarat
records; PRT, prerace training; PRY, years of regular endurance running; IM, ultrama
Bold numbers mark significant P-values of the test on difference between F and NFendurance prerace performance or mal-alignment of the
legs (which was only seen in one female subject suffering
from a bunion). The majority of the participants was
able to ‘overrun’ more or less severe overuse soft tissue
syndromes in the legs and reached the finish line [2].
This indicates, that, despite the mentioned somatic
parameters, other mentally based factors, such as pain
resistance and personality traits, are also relevant forween F/NF regarding prerace performance indices





NF statistic P test typea P b
18.7 0.936 0.185c ITT 0.530
194.3 0.481 0.000 MWU 0.211
86.0 0.858 0.005 MWU 0.895
5.4 0.936 0.165c ITT 0.146
88.0 (20.8) 0.959 0.505c ITT 0.032d
11.9 0.971 0.761c ITT 0.427
7.5 (0.93) 0.909 0.044 MWU 0.040d
89.7 (17.4) 0.956 0.435c ITT 0.010d
12.0 0.947 0.303c ITT 0.159
3.1 0.851 0.018 MWU 0.676
5.1 (0.26) 0.914 0.343c ITT 0.026d
10.4 0.933 0.248c ITT 0.241
59.7 0.918 0.238c ITT 0.218
87.3 0.940 0.548c ITT 0.558
168.5 (26.0) 0.961 0.672c ITT 0.036d
5): normal distribution accepted; dmean differences between finishers and
hon; MWU: Mann–Whitney-U test; n, number; NF, non-finishers; PRR, prerace
rathon.
.
Figure 18 Correlation (one-tailed test) of percentage volumes and prerace performance.
Figure 19 Correlation of adipose and lean volumes at start with performance at TEFR09. TEFR09, Transeurope Footrace 2009.
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[70]. One subject (male, 61 years old) had to stop the
race after stage 38 (2,601 km run) due to a high tibial
stress fracture which was detected in a specific MRI on
at this day (Figure 15). The astonishing thing is not the
stress fracture, because this can happen to every ultra
runner when starting a transcontinental race, but the
fact that the major pain and massive performance (run-
ning velocity) loss had already started at stage 36. This
subject ran 228 km (three stages) with a complete high
tibial fracture before stopping the race, because he
interpreted the pain as a soft tissue injury due to overuse
and tried to ‘overrun’ it before he asked for MRI control.
Another participant (female, 46 years old) showed the
same behavior when running 208 km (stage 46 to 48)
with a ventral pelvic ring stress fracture before diagnosis
could be done with mobile MRI [2]. These examples and
our prerace test on pain tolerance demonstrate that the
resilience of the ultra athletes regarding pain is signifi-
cantly higher than in a normal control group [70].
Body composition and performance
In specific treadmill investigations under laboratory
settings, Millet et al. showed that a good single ultra-
marathon performance needs specific running economy
depending on the ability of maximal oxygen uptake be-
ing highly correlated with citrate synthase activity and
capillary network [71]. These physiological factors have
not been investigated directly under race conditions in
ultra-endurance events until now. Concerning this
matter, only indirect parameters, such as anthropometric
characteristics, are examined.
Several anthropometric factors are reported to affect
performance in runners, but the presented data are
inconsistent and often contradictory. Such differences
are also present in the specific literature regarding
anthropometrical predictors of performance outcome in
ultra-marathons. Several factors are responsible for this.
The numbers of volunteers are different, and in most
reports they are limited and differ in gender and ethnic
origin. Furthermore, the investigations are based on
manifoldly different types of UM races. They can differ
in the distance of running and number of stages, but
also in altitude and/or external conditions.
Anthropometric parameters related to good perform-
ance are different in marathons and middle distance (half-
marathon, 10 km) events [72]. Knechtle et al. reported
that anthropometry is not associated with performance in
single mono-stage UM races (24 hours [73]).
In MSUM Knechtle et al. found no correlation between
BM or body fat (BIA) and race performance in a 17-stage
MSUM (‘Deutschlandlauf 2007’, 1,200 km) [68]. In a
cohort of 392 athletes, Hoffman found a significant rela-
tionship of BMI to finishing times in mono-stage UMrunning (161 km UM) [74]. In single marathon runners
abdominal and front thigh SF are correlated [75]. The sum
of eight SF-locations correlated significantly to 100 km
race-time in a survey of three races in Knechtle et al. [76].
According to our results with a group of 22 subjects
and using gold standard whole body MRI, in athletes
taking part in a 64-day MSUM there are no relevant cor-
relations between total volume, percentage fat and lean
volumes of different compartments at the start and total
race performance of subjects participating in TEFR09.
For SAST, a significant correlation between percentage
volume at the start and cumulative performance is seen
at the beginning of TEFR09 (stages 1 to 8), but only at a
medium to low effect size. Correlation of percentage fat
and lean volumes to performance at the individual stages
could only be shown in a few stages at a medium to low
effect size. Looking at percentage volume distribution,
the participants already started with a low percentage of
body fat. Therefore, our results might confirm earlier
findings of a negative relationship between the amount
of subcutaneous fat tissue (thickness or volume), being
the main fat tissue compartment of the body, and per-
formance in single or multiday ultramarathon races.
However, in a multistage ultramarathon over thousands
of kilometers we found no relationship between body fat
percentage or BM or BV and race performance using
specific whole body MRI, as Knechtle et al. did with BIA
[68]. The majority of transcontinental MSUM partici-
pants ran not for winning but for finishing the race;
therefore, running velocity was a priority only for a few
of them. For single UM races, the race time and, there-
fore, the performance plays a more important role for
the ultra-athletes, and body composition and fat distri-
bution have a more significant influence, respectively.
Similar interpretation has to be done, when looking at
segmental (somatic) tissue changes in the arms, legs and
trunk during TEFR09. As for adipose and lean total
somatic and visceral volumes (Figure 19), we also did an
analysis of the relationship between segmental tissue vol-
ume changes and race performance (results not demon-
strated graphically) and detected only a small to low
medium effect size for correlations between SAST of all
segments (UE, TR, LE) with cumulative race perform-
ance in the first eight stages of TEFR09. So, in our inves-
tigation, all segments show a significant relationship to
race performance that is similar to that of SAST over all
(Figure 19) without any exceptional segment findings,
which explains the inconstant finding in the literature.
Knechtle et al. [77] found an association between triceps
SF thickness and performance in female 100 km ultra-
runners. Tanaka and Matsuura mentioned this for CF of
the thigh in the early eighties [78].
Some ultra athletes show adaption to the intense run-
ning burden of TEFR09 with muscle (SLT) increase in
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ning. These findings were not significant in the mean. For
the trunk, a mean increase of SLT could also be detected
in the first third of the race. This is explained by the glu-
teal and psoas muscles, which are part of the active motor
system of the lower extremities but anatomically are
placed in the trunk in our segmentation. All lean tissue
segments showed a decrease in their volumes towards the
end of TEFR09, indicating the high negative energy bur-
den of transcontinental running.
Metabolic changes
After the first thousand kilometers the mean loss of TV
per km, mainly caused by the SAST and VAT decrease,
declined constantly up to more than half until the end
of race (Figure 11). Despite lack of documentation of the
nutrition and caloric intake but knowing that the sub-
jects tried to ensure an optimum of energy intake, the
decrease of fat volume loss can be explained by two fac-
tors: relevant metabolic changes regarding energy balan-
cing [79] and improvement and optimization of running
style during progression of the race. Not in multistage but
in single stage ultra-running conditions such economical
adaptations have already been shown by Millet et al.
[80-82]. They could show significant changes of running
mechanics and spring-mass behavior towards a higher
mean step frequency (+4.9%) with shorter ground-feet
contact time (−4.5%) and lower ground reaction force
(−4.4%) due to functional leg length decrease (−13%) and
increase of leg (+9.9%) and vertical stiffness (+8.6%) du-
ring the support phase of running between the early phase
and the end of a 24-hour treadmill run [80]. Millet et al.
speculated that these changes in running mechanics con-
tributed to the overall limitation of the potentially harmful
consequences of such a long-duration run on the subjects’
musculoskeletal system. Transferred to MSUM condi-
tions, such changes in running mechanics may also con-
tribute to the necessity of the organism to optimize the
running economy to a high-end level (as low an energy
consumption as possible) due to the massive negative en-
ergy burden a transcontinental race requires. The changes
Millet et al. [80] and other researchers had measured
[83,84] describe a running technique which requires only
a low muscle power, because forceful eccentric load and
step length are reduced. Besides the reduction of overuse
risk for the musculoskeletal system this reduces the energy
demand of the organism as well [85], even if the under-
lying mechanisms of the relation between energy cost of
running and step variability remains unclear until now. If
running economy could not be sacrificed in ultramarathons
[86,87] and the amount of change in running mechanics
depends on the duration of running and distance towards a
fatigue state, respectively [81,85], it is even mandatory in
transcontinental MSUM. Every subject in the TEFR-projectshowed a significant loss of BM and TV throughout the
race, independent of the prerace overall status of body
composition and performance or nutrition behavior during
the race. The massive negative energy burden of a 4,500
km MSUM is also indicated by the significant loss of the
grey matter in the brain [88]. The analysis of specific
laboratory markers of the required blood and urine samples
may give more data about the metabolic changes during
TEFR09 in the near future.
Limitations
There was no general or individual nutrition plan offered
or generated for the participants of TEFR09 or subjects
of the TEFR-project, respectively. The athletes had a
breakfast and a dinner served in different locations at
the stage destinations, but these meals were organized
and oriented at the local level at the last minute. The
food supply points during the stages also offered prod-
ucts that changed every day and the athletes took add-
itional individual food on their own throughout the
race [2]. Therefore, documentation and measurement
of nutrition and caloric intake was not possible and a
stringent documentation of nutrition by the subjects
implied the risk of compliance problems.
Whole body mobile MRI protocols did not measure
ectopic fat such as intracellular fat of organs (for
example liver) and muscles (intramyocellular lipids:
IMCL). For IMCL measurement, specific protocols for
mobile 1H-MR-spectroscopy of the muscles of the lower
legs were implemented in the TEFR-project [2]. How-
ever, due to the dependence of this MR-method on a
stable external magnetic field around the magnetom, the
analysis of mobile1H-MR-spectroscopy during TEFR09
did not lead to valid data and needed further development
and implementation of post-imaging proof algorithms.
Conclusions
With this mobile MRI field study a complex change in
body composition during an ultra-long MSUM could be
demonstrated in detail. IAAT (VAT) shows the fastest
and highest decrease compared to SAST and lean tissue
compartments during TEFR09. Participants lost more
than half of their adipose soft tissue and even lean tissue
volume decreased (mainly skeletal muscle tissue). With-
out exception, every subject showed a significant loss of
body volume. This indicates that running an MSUM of
nearly 4,500 km without any day of rest is linked with
an unpreventable chronic negative energy balance due
to the massive running burden. The ratio of adipose
tissue contribution between the visceral and somatic
compartments has a significant influence on dropping
out of the race during the first third in a MUSM due to
overuse injuries of the myotendinous fascial system of
the legs. Body volume or body mass and, therefore, fat
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athletes finishing a 64-stage UM. Two- and three-
compartment methods, such as bioelectrical impedance
analysers and skinfold-equations, cannot give estimations
about the relationship between the visceral and somatic
compartments and, therefore, cannot measure the most
sensitive anthropometric predictor of not finishing a
MSUM: VAT. Running economy is mandatory for trans-
continental MSUM races and, even in well trained ultra-
athletes, such events lead to further adaptation of running
mechanics and to metabolic changes as performance ana-
lysis compared to body composition changes throughout
the race indicates.Abbreviations
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